Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial
- PMID: 29064958
- DOI: 10.1097/AOG.0000000000002339
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial
Comment in
-
In Reply.Obstet Gynecol. 2017 Nov;130(5):1157-1158. doi: 10.1097/AOG.0000000000002340. Obstet Gynecol. 2017. PMID: 29064959 No abstract available.
Comment on
-
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial.Obstet Gynecol. 2017 Apr;129(4):615-620. doi: 10.1097/AOG.0000000000001928. Obstet Gynecol. 2017. Retraction in: Obstet Gynecol. 2020 Apr;135(4):980. doi: 10.1097/AOG.0000000000003836. PMID: 28277352 Retracted. Clinical Trial.
References
-
- Maher MA, Sayyed TM, Elkhouly N. Sildenafil citrate therapy for oligohydramnios: a randomized controlled trial. Obstet Gynecol 2017;129:615–20.
-
- Sovio U, White IR, Dacey A, Pasupathy D, Smith GC. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study. Lancet 2015;386:2089–97.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
